Customize your JAMA Network experience by selecting one or more topics from the list below.
JAMA Dermatology thrived in 2018, receiving a substantial boost in impact factor to 8.11, ranking it high among all dermatology journals. The journal received 1600 manuscript submissions in the past year, up from 1271 in 2017 and 1190 in 2016, and welcomed half its submissions from international author teams. In 2018, 912 of 1600 submissions (57%) were research articles and 14% were accepted for publication. The journal published many important research articles, including 15 randomized clinical trials. Reducing the time to publication continues to be an ongoing goal for the journal, with a median reviewer turnaround time of 9 days, median receipt to a first decision without peer review time of 3 days and 37 days with peer review, and a median acceptance to publication time of 71 days. The editorial leadership team aims to find ways to improve the editorial and review processes to ensure authors the most timely and efficient publication of their work.
JAMA Dermatology continued to have broad digital and social media reach, with 3.8 million full-text views and downloads in the past year, and connected with more than 45 000 followers on Twitter and Facebook. The journal received 6444 media mentions this year, another important indicator of the journal’s success. One of the measures of the reach of the articles that are published in JAMA Dermatology is the Altmetric score, which is a measure of news and social media coverage. Three JAMA Dermatology articles1-3 were among the Altmetric top-scoring dermatology articles in 2018, and the first 21,2 of these ranked at the highest Altmetric scores in dermatology journals for the year (Table1-3). More noteworthy articles, including those with the highest number of views and downloads4-6 and the ones most cited by other journals,7-9 can also be seen in the Table.
The journal featured important research that informs and changes our clinical practices, including recommendations for the management of dysplastic nevi,10 diet in psoriasis,11 and venous leg ulcers.12 It also offered vital self-reflections for our specialty on machine learning and diversity,13 private equity,14 dermatology physician assistants,15 and the need for an improved understanding of the best dermatologic care of transgender persons.16
In July, the editorial leadership expanded and now represents different subspecialties to enhance the expertise and reach of the journal and provide readers with the most balanced content. Major changes were implemented with this leadership transition, including these highlights:
Monthly author interview podcasts feature Adewole Adamson, MD, MPP, University of Texas at Austin, the journal’s new web editor and podcast host, with 23 109 listener podcast downloads over the past year.
The journal introduced the Images in Dermatology section, expertly edited by coeditors Lauren Madigan, MD, University of Utah, and Robert Micheletti, MD, University of Pennsylvania, which received 180 submissions since its debut.17
Researcher and editorial conflicts of interests have been in the news this year; this fall, JAMA Dermatology adopted the questions from the International Committee of Medical Journal Editors (ICMJE) form for transparent reporting of potential conflicts of interest for authors and our editors, consistent with changes across JAMA Network.18
To elevate the scientific rigor of JAMA Dermatology, substantial efforts were led by our quantitative methods editor, Ivo Abraham, PhD, University of Arizona, to expand the statistical expertise at the journal and broaden the involvement of expert statistical reviewers of research submissions. In the upcoming year, we will offer new ways for statistical reviewers to be identified based on their methodological expertise(s).
We thank Jeremy Bordeaux, MD, MPH, Case Western Reserve University, for his years of service to the journal as an associate editor and editorial board member and welcome Jeremy Etzkorn, MD, University of Pennsylvania, as a new associate editor and procedural dermatology expert.
Additional plans for the upcoming year include an increased journal presence at clinical and scientific meetings to identify the best research and to connect with readers, authors, and potential authors. The journal now offers monthly clinical review articles to ensure that our readers have high-yield summaries of scientific evidence that is relevant to their clinical practice. Our energetic CME/Clinical Review and Education editor, Kari Wanat, MD, Medical College of Wisconsin, is working to expand the options available for readers to gain CME credit by taking monthly online quizzes. The journal will continue its partnership with the American Board of Dermatology to offer access to selected journal articles for Maintenance of Certification. An additional new feature across JAMA Network will be visual abstracts for randomized clinical trials. JAMA Network also offers new ways of accessing free journal content, with direct access to the JAMA Dermatology’s content for all recipients of the weekly electronic table of contents.
Our editorial leadership team continues its firm commitment to the journal’s mission statement.19 Achieving this mission is only possible through the efforts and feedback of dedicated reviewers, editors, editorial board members, JAMA Network colleagues, and readers. I thank all of you. I personally want to thank deputy editor Misha Rosenbach, MD, University of Pennsylvania, and editorial manager Constance Murphy for their close support and collaboration on daily journal operations.
Insights and suggestions from peer reviewers inform our editorial decisions and improve our submissions on their path to publication. I thank the 844 reviewers20 who generously volunteered their time and expertise on behalf of the journal.
In the era of ever-increasing “pajama time” (ie, the time later in the day or on weekends that physicians spend to meet escalating clinical documentation and patient care expectations), I hope to ensure that JAMA Dermatology continues to be an oasis of learning for dermatologists and dermatology trainees to pursue and enjoy lifelong learning. It is a pleasure and privilege to read the many submissions that reflect the latest research, developments, and opinions about dermatology as a specialty and to publish the most relevant and potentially practice-changing articles. I look forward to continuing to learn together with our readers in the coming year and hearing your feedback and suggestions.
Corresponding Author: Kanade Shinkai, MD, PhD, Department of Dermatology, University of California–San Francisco, 1701 Divisadero St, 3rd Floor, San Francisco, CA 94115 (email@example.com).
Published Online: March 20, 2019. doi:10.1001/jamadermatol.2019.0161
Conflict of Interest Disclosures: None reported.
Shinkai K. JAMA Dermatology—The Year in Review, 2018. JAMA Dermatol. 2019;155(5):527–528. doi:10.1001/jamadermatol.2019.0161
Monkeypox Resource Center